244 related articles for article (PubMed ID: 8440305)
1. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
Kihara T; Ikeda M; Matsubara K; Matsushita A
Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
[TBL] [Abstract][Full Text] [Related]
2. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
[TBL] [Abstract][Full Text] [Related]
3. Ceruletide, a CCK-like peptide, attenuates dopamine release from the rat striatum via a central site of action.
Kihara T; Ikeda M; Ibii N; Matsushita A
Brain Res; 1992 Aug; 588(2):270-6. PubMed ID: 1393578
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin.
Hernandez L; Lee F; Hoebel BG
Brain Res Bull; 1987 Dec; 19(6):623-8. PubMed ID: 2449936
[TBL] [Abstract][Full Text] [Related]
5. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats.
Whishaw IQ; Fiorino D; Mittleman G; Castañeda E
Brain Res; 1992 Mar; 576(1):1-11. PubMed ID: 1381257
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine enhances extracellular concentrations of dopamine and acetylcholine in dorsolateral striatum and nucleus accumbens of freely moving rats.
Guix T; Hurd YL; Ungerstedt U
Neurosci Lett; 1992 Apr; 138(1):137-40. PubMed ID: 1407652
[TBL] [Abstract][Full Text] [Related]
7. Influence of potassium concentration in microdialysis perfusate on basal and stimulated striatal dopamine release: effect of ceruletide, a cholecystokinin-related peptide.
Kihara T; Ikeda M; Miyazaki H; Matsushita A
J Neurochem; 1993 Nov; 61(5):1859-64. PubMed ID: 8228999
[TBL] [Abstract][Full Text] [Related]
8. Ceruletide suppresses endogenous dopamine release via vagal afferent system, studied by in vivo intracerebral dialysis.
Hamamura T; Kazahaya Y; Otsuki S
Brain Res; 1989 Mar; 483(1):78-83. PubMed ID: 2706512
[TBL] [Abstract][Full Text] [Related]
9. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347
[TBL] [Abstract][Full Text] [Related]
10. Amphetamine-induced effects on neuropeptide Y in the rat brain.
Obuchowicz E; Turchan J; Przewłocki R; Herman ZS
Pharmacol Rep; 2005; 57(3):321-9. PubMed ID: 15985714
[TBL] [Abstract][Full Text] [Related]
11. The neurochemical basis for the behavioral effects of triadimefon.
Hill D; Ikaiddi M; Mazzio E; Soliman KF
Ann N Y Acad Sci; 2000 Sep; 914():336-53. PubMed ID: 11085334
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics.
Kuczenski R; Segal DS; Aizenstein ML
J Neurosci; 1991 Sep; 11(9):2703-12. PubMed ID: 1715389
[TBL] [Abstract][Full Text] [Related]
13. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
Eur J Pharmacol; 1991 Mar; 195(1):63-73. PubMed ID: 2065713
[TBL] [Abstract][Full Text] [Related]
14. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat.
Hamilton M; Sheehan MJ; De Belleroche J; Herberg LJ
Neurosci Lett; 1984 Jan; 44(1):77-82. PubMed ID: 6717857
[TBL] [Abstract][Full Text] [Related]
15. Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study.
Hagino Y; Moroji T
Brain Res; 1994 Apr; 644(1):40-6. PubMed ID: 8032948
[TBL] [Abstract][Full Text] [Related]
16. Cortical cholinergic deficiency enhances amphetamine-induced dopamine release in the accumbens but not striatum.
Mattsson A; Olson L; Svensson TH; Schilström B
Exp Neurol; 2007 Nov; 208(1):73-9. PubMed ID: 17714706
[TBL] [Abstract][Full Text] [Related]
17. Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.
Kihara T; Ikeda M; Matsushita A
Brain Res; 1990 Jun; 519(1-2):44-9. PubMed ID: 2397417
[TBL] [Abstract][Full Text] [Related]
18. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
Ichikawa J; Meltzer HY
Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
[TBL] [Abstract][Full Text] [Related]
19. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens.
Kolta MG; Shreve P; Uretsky NJ
Neuropharmacology; 1989 Jan; 28(1):9-14. PubMed ID: 2927583
[TBL] [Abstract][Full Text] [Related]
20. The effect of environmental enrichment on amphetamine-stimulated locomotor activity, dopamine synthesis and dopamine release.
Bowling SL; Rowlett JK; Bardo MT
Neuropharmacology; 1993 Sep; 32(9):885-93. PubMed ID: 8232791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
